EMR and F4/80CRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。EMR and F4/80遺伝子サイレンサーは、EMR and F4/80 CRISPR/Cas9ノックアウトプラスミドとEMR and F4/80Double Nickaseプラスミドとして利用可能です。遺伝子活性化用のEMR and F4/80CRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
EMR and F4/80 CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
EMR1 CRISPR/Cas9 KOプラスミド (h) | sc-400698 | h | Gene Knockout | GFP | 0 | ||
EMR1 HDRプラスミド (h) | sc-400698-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
EMR1 Double Nickaseプラスミド (h) | sc-400698-NIC | h | Gene Knockout | Puromycin | 0 | ||
EMR1 Double Nickaseプラスミド (h2) | sc-400698-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
EMR2 CRISPR/Cas9 KOプラスミド (h) | sc-409262 | h | Gene Knockout | GFP | 0 | ||
EMR2 HDRプラスミド (h) | sc-409262-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
EMR2 Double Nickaseプラスミド (h) | sc-409262-NIC | h | Gene Knockout | Puromycin | 0 | ||
EMR2 Double Nickaseプラスミド (h2) | sc-409262-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
EMR3 CRISPR/Cas9 KOプラスミド (h) | sc-410628 | h | Gene Knockout | GFP | 0 | ||
EMR3 HDRプラスミド (h) | sc-410628-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
EMR3 Double Nickaseプラスミド (h) | sc-410628-NIC | h | Gene Knockout | Puromycin | 0 | ||
EMR3 Double Nickaseプラスミド (h2) | sc-410628-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
F4/80 CRISPR/Cas9 KOプラスミド (m) | sc-420168 | m | Gene Knockout | GFP | 0 | ||
F4/80 Double Nickaseプラスミド (m) | sc-420168-NIC | m | Gene Knockout | Puromycin | 0 | ||
F4/80 Double Nickaseプラスミド (m2) | sc-420168-NIC-2 | m | Gene Knockout | Puromycin | 0 |
EMR and F4/80 CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
EMR1 CRISPR Activationプラスミド (h) | sc-400698-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EMR1 CRISPR Activationプラスミド (h2) | sc-400698-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EMR1 Lentiviral Activation Particles (h) | sc-400698-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EMR1 Lentiviral Activation Particles (h2) | sc-400698-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EMR2 CRISPR Activationプラスミド (h) | sc-409262-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EMR2 CRISPR Activationプラスミド (h2) | sc-409262-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EMR2 Lentiviral Activation Particles (h) | sc-409262-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EMR2 Lentiviral Activation Particles (h2) | sc-409262-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EMR3 CRISPR Activationプラスミド (h) | sc-410628-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EMR3 CRISPR Activationプラスミド (h2) | sc-410628-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EMR3 Lentiviral Activation Particles (h) | sc-410628-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EMR3 Lentiviral Activation Particles (h2) | sc-410628-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
F4/80 CRISPR Activationプラスミド (m) | sc-420168-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
F4/80 CRISPR Activationプラスミド (m2) | sc-420168-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
F4/80 Lentiviral Activation Particles (m) | sc-420168-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
F4/80 Lentiviral Activation Particles (m2) | sc-420168-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |